Patients with CAD had a significantly elevated RCN2 levels in comparison to healthy subjects (55.3 ± 3.9 vs. 18.5 ± 2.0 ng/mL; p < 0.001) (Figure 4). Here, RCN2 is linked to coronary artery disorder.